1/9
Looks like no tags are added yet.
A small effector molecule induces transcription. Which combination below is consistent with this idea?
Repressor and inducer
Activator and inhibitor
Repressor and corepressor
None of the above
Repressor and inducer
With regard to lac operon regulation via catabolite activator protein (CAP), which of the following statements is correct?
Glucose lowers cAMP levels. CAP binds to the DNA when cAMP is bound to CAP.
Glucose lowers cAMP levels. CAP does not bind to the DNA when cAMP is bound to CAP.
Glucose raises cAMP levels. CAP binds to the DNA when cAMP is bound to CAP.
Glucose raises cAMP levels. CAP does not bind to the DNA when cAMP is bound to CAP.
Glucose lowers cAMP levels. CAP binds to the DNA when cAMP is bound to CAP.
Let's suppose you have isolated a mutant strain of E. coli in which the lac operon is constitutively expressed. You create a merozygote in which the mutant strain also contains an F' factor with a normal lac operon and a normal lacI gene. You then compare the mutant strain and the merozygote with regard to their β-galactosidase activities in the presence and absence of lactose. You obtain the following results:
Strain Addition of lactose (no glucose) Amount β-Galactosidase
Normal Yes 100
Mutant No 100
Mutant Yes 100
Merozygote No 100
Merozygote Yes 200
Which of the following is consistent with these data?
The mutation is in the lacI gene and results in a lac repressor that cannot bind to the operator
The mutation is in the lac operator and prevents the lac repressor from binding to the operator
The mutation is in the lacI gene and results in a lac repressor that cannot bind allolactose
All of the above
The mutation is in the lac operator and prevents the lac repressor from binding to the operator
For a riboswitch that controls transcription, what is the effect of a regulatory molecule such as TPP?
It binds to a repressor and causes the repressor to bind to an operator site.
It binds to an activator and causes the activator to bind to an operator site.
It binds to an RNA molecule and causes a change in its conformation.
It binds directly to the promoter and prevents transcription.
It binds to an RNA molecule and causes a change in its conformation.
Let's suppose that mediator has interacted with an activator protein. What would you expect to happen next?
TFIID would bind to the core promoter.
RNA polymerase would bind to the core promoter.
Histones would be displaced from the core promoter.
RNA polymerase would switch to the elongation phase of transcription.
RNA polymerase would switch to the elongation phase of transcription.
With regard to eukaryotic gene transcription, histones are not removed during
the formation of the preinitiation complex.
transcriptional elongation.
phosphorylation of CTD.
the formation of nucleosome-free regions.
phosphorylation of CTD.
The following list describes events that are required for transcription of a eukaryotic gene. Put them in the correct order.
Elongation
Binding of activators
Chromatin remodeling and histone modification
Formation of the pre-initiation complex
2, 3, 4, 1
1, 4, 2, 3
4, 3, 2, 1
2, 1, 4, 3
2, 3, 4, 1
During the phenomenon of proximal promoter pausing,
the CTD (carboxyl terminal domain) of RNA polymerase gets phoshorylated.
RNA polymerase stops transcribing the DNA due to the binding of NELF (negative elongation factor) and DSIF (DRB-sensitivity-inducing factor).
TFIIH converts the preinitiation complex into an open complex.
TFIIB, TFIIE, TFIIH, and mediator are released from RNA polymerase.
RNA polymerase stops transcribing the DNA due to the binding of NELF (negative elongation factor) and DSIF (DRB-sensitivity-inducing factor).
Which of the following event(s) need to happen for the glucocorticoid receptor to activate a gene?
Protein-protein interaction (e.g., dimer formation)
The binding of the glucocorticoid receptor to a GRE
The binding of a small effector molecule to the glucocorticoid receptor subunits
all of the above happen
all of the above happen
Which of the following phenomena could you study using ChIp-Seq?
To see if a regulatory transcription factor binds to mediator and/or TFIID
To measure the level of transcription of a given gene in real time.
To analyze the binding of protein(s) to DNA on genome-wide scale.
To determine if a mutation at a regulatory site alters the transcription level of a given gene.
To analyze the binding of protein(s) to DNA on genome-wide scale.